GE HealthCare Technologies Inc. (LON:0ADL)

Market Cap	26.46B -18.0%
Revenue (ttm)	15.32B +4.8%
Net Income	1.55B +4.6%
EPS	3.38 +4.8%
Shares Out	n/a
PE Ratio	17.09
Forward PE	15.70
Dividend	0.10 (0.13%)
Ex-Dividend Date	Jan 9, 2026

Volume	19
Average Volume	201
Open	78.80
Previous Close	79.27
Day's Range	78.80 - 78.80
52-Week Range	64.49 - 92.38
Beta	n/a
RSI	46.50
Earnings Date	Feb 4, 2026

About LON:0ADL

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, an...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2022
• Employees: 54,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ADL

Financial Performance

In 2025, LON:0ADL's revenue was $20.63 billion, an increase of 4.84% compared to the previous year's $19.67 billion. Earnings were $2.08 billion, an increase of 4.57%.

Financial numbers in USD